#Food and Drug Administration

With the approval of Cyramza, there are now five targeted therapies for hepatocellular carcinoma.

Unused medication needs to be disposed of safely.

In a recent statement, the Food and Drug Administration underscored the need for better technologies to protect the nation’s blood supply.

Ned Sharpless has been appointed interim head of the regulatory agency after the unexpected resignation of the commissioner.

The head of the Food and Drug Administration cited a long commute and time away from family as reasons to step down.

McKesson is under scrutiny after claims it failed to identify, quarantine and investigate drug shipments that had been tampered with.

The FDA’s revision was based on two randomized trials of Viread (tenofovir disoproxil fumarate) use in 2- through 11-year-olds.

Gilead Sciences has released multiple combo tablets that contain the updated tenofovir, which is linked to improved bone and kidney makers.

Congress passes legislation to increase access to unapproved therapies for life-threatening diseases.

Experts warn that the plant, which is used to treat pain and symptoms of withdrawal from heroin, can be dangerous — and even deadly.

He’ll oversee the FDA, Medicare and Medicaid at a time when soaring drug prices remain a contentious political topic.

FDA warns companies marketing unproven products, derived from marijuana, that claim to treat or cure cancer

Puerto Rico’s main exports are medical devices and pharmaceuticals, including HIV and cancer drugs.

A formal petition filed with federal drug regulators last week seeks to prevent thousands of accidental overdose deaths every year.

The Food and Drug Administration has approved AbbVie’s once-daily Mavyret to treat all six major genotypes of hepatitis C virus (HCV).

It approved 12 weeks of Gilead Sciences’ Vosevi for the re-treatment of adults with all genotypes of HCV who do not have cirrhorsis.